Robert Samstein

Mount Sinai Hospital — United States

Medicine · Health Sciences

39h-index17.6kcitations126works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(41), Cancer Genomics and Diagnostics(21), Lung Cancer Treatments and Mutations(17), Immunotherapy and Immune Responses(14), Lung Cancer Diagnosis and Treatment(13)

Publications122 total

Abstract C070: Targeting neoantigens conserved across organs and species overcomes tumor immune escape
Cancer Immunology Research·2026
Abstract C027: STING-mediated Myeloid Reprogramming Drives Immunotherapy Response in DNA Repair Mutant Tumors
Cancer Immunology Research·2026
Targeting Neoantigens Conserved Across Organs and Species Overcomes Tumor Immune Escape
SSRN Electronic Journal·2026Open Access
PP01.23/OA07.01: Myeloid IL-1 Signaling Drives The Precancer-to-Cancer Evolution of Human Pulmonary Nodules
Journal of Thoracic Oncology·2026
Mismatch repair deficiency drives malignant progression and alters the tumor immune microenvironment in glioblastoma models
Journal of Clinical Investigation·2025Open Access
Coordinated macrophage and T cell interactions mediate response to checkpoint blockade in colorectal cancer
2025Open Access
Somatic mutations in T cells promote antitumour response
Nature reviews. Immunology·2025
Immunogenetics of cancer risk 3678
The Journal of Immunology·2025Open Access
Immunogenetics of cancer risk: an emerging role for HLA class II 2623
The Journal of Immunology·2025Open Access
Identifying targets of precancerous neoantigen-specific T cell surveillance in patients with Lynch syndrome and immune suppression programs supporting colorectal cancer progression 3671
The Journal of Immunology·2025Open Access
Defining the determinants of immune response in DNA homologous recombination deficient tumors 3797
The Journal of Immunology·2025Open Access
PlanAct: An eclipse scripting API‐based module embedding clinical optimization strategies for automated planning in locally advanced non‐small cell lung cancer
Journal of Applied Clinical Medical Physics·2025· 1 citedOpen Access
The Role of Immunotherapy and Radiation Therapy in the Treatment of Breast Cancer
Biomedicines·2025· 2 citedOpen Access
Can Generative AI Agents Match the Experts? Measuring Large Language Model Performance in Evaluating NSCLC Treatment Plans
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
Knowledge‐based trade‐off prediction for NSCLC treatment planning using multi‐output regression
Medical Physics·2025· 1 cited
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers
Nature Communications·2025· 1 citedOpen Access
Impact of Normal Lung Volume Choices on Radiation Pneumonitis Risk Prediction in Locally Non-small Cell Lung Cancer Radiation Therapy
Advances in Radiation Oncology·2025Open Access
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC
Journal of Thoracic Oncology·2025· 6 citedOpen Access
Abstract CT106: A phase 1b/2 trial of dupilumab given in conjunction with PD-1 or PD-L1 blockade and anakinra in the treatment of relapsed/refractory metastatic NSCLC
Cancer Research·2025
Transforming Brain Tumor Care: The Global Impact of Radiosurgery in Multidisciplinary Treatment Over Two Decades
Cancer Medicine·2025· 2 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Luc G.T. Morris(13), Nadeem Riaz(10), Timothy A. Chan(10), Fengshen Kuo(7), Alexander Y. Rudensky(7), Ahmet Zehir(6), Christopher A. Barker(6), Miriam Mérad(6), Diego Chowell(6), Vladimir Makarov(6), Chirag Krishna(6), Miriam Saffern(5), Nina Bhardwaj(5), Douglas R. Hoen(5), Raja M. Flores(5), Cristina Valero(5), Andreas Rimner(5), Alexander N. Shoushtari(4), A. Ari Hakimi(4), Nancy Y. Lee(4)